Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal epithelial barrier

Abstract

Abstract Several studies have found exogenous H2 treatment can alleviate inflammatory damage in inflammatory bowel disease (IBD) animal models, but the mechanisms behind it are less clearly understood. The present study aimed to investigate whether hydrogen-rich saline (HS) attenuates IBD in mice model and the underlying mechanisms. The results showed that HS administration significantly inhibit weight loss and reduce inflammatory damage in dextran sulfate sodium (DSS)-induced acute ulcerative colitis (UC) mice model. We observed that H2 regulates the composition of microbiota by up-regulating the abundance of intestinal specific short chain fatty acids (SCFAs)-producing bacteria. Increased butyrate-producing microbes activated the intracellular butyrate sensor peroxisome proliferator–activated receptor γ (PPAR-γ) signaling pathway, meanwhile decreased the epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, and thus promoted the recovery of colonic anaerobic environment. Our results also indicated that HS administration reduce intestinal epithelial barrier permeability by decreasing the dextran concentrations in serum, inhibit dysbiotic Enterobacteriaceae expansion, increasing mucus secretion in the colonic lumen, and promoting the expression of intestinal interepithelial tight junction protein. Taken together, we identified the mechanism by which exogenous H2-improved “microbial hydrogen economy” regulates metabolic reprogramming of colonocyte through microbiota-activated PPAR-γ signaling pathway to provide colonic anaerobic environment, and reinforces intestinal epithelial barrier function, thereby promoting the recovery of intestinal homeostasis.